Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

Trial Profile

Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Apatinib (Primary) ; Capecitabine; Oxaliplatin
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 31 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top